HOME >> BIOLOGY >> NEWS
Academic clinical research is under threat from the EU

Copenhagen, Denmark: New therapies for hard-to-treat or rare cancers might never be developed and patients would continue to suffer and die unless problems with the proposed EU directive[1] on clinical trials are resolved, a leading cancer expert warned today in a news briefing at ECCO12 The European Cancer Conference.

Academic clinical research will grind to a halt under the bureaucratic burden proposed by the EU, according to Jaap Verweij, professor of medical oncology at the Erasmus Medical Center in Rotterdam.

He said that international collaborations on clinical trials were vital for translating the results of laboratory research quickly into benefits for patients. Yet the EU's plans could make such collaborations difficult, if not impossible, thereby stifling important research and condemning many patients to death or years of suffering because they would be unable to benefit from new and better treatments for their cancers.

The discovery of a new and effective treatment for a rare and difficult-to-treat cancer has highlighted the way international collaboration can be translated into benefits for patients in a short time-scale that would be impossible if the research had to be carried out in only one country, said Prof Verweij.

"Sarcomas are a very rare collection of cancers of connective tissues such as bone, muscle, cartilage, fibrous tissue and blood vessels," explained Prof Verweij. "They represent only one per cent of all cancers. One of these is gastrointestinal stromal tumour (GIST), which arises from the connective tissue of the gastrointestinal tract. This is a very difficult cancer to treat successfully and for those patients who cannot be treated by surgery, the prognosis is poor, with an average survival of only one year.

"Recently, scientists recognised that it might be possible to control the disease by inhibiting the c-Kit gene, mutations in which were thought to control GIST. They found
'"/>

Contact: Emma Mason
wordmason@aol.com
45-3252-4163
Federation of European Cancer Societies
25-Sep-2003


Page: 1 2 3

Related biology news :

1. Cedars-Sinai Medical Center Physicians And Scientists Present Findings At Annual Meeting Of The Pediatric Academic Societies
2. School Breakfast Participation Leads To Academic, Psychosocial Improvements
3. Pediatric Academic Societies Report Progress In Childrens Health
4. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
5. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
6. Innovative ceramic-on-metal hip replacements to undergo clinical trials
7. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
8. Warren Pharmaceuticals publishes results of preclinical evaluation
9. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
10. Scientists characterize new breast tumor subtypes with poor clinical outcomes
11. Uncertainty in clinical tests raises health care costs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: